Thermo Fisher Scientific Inc. closed 16.60% short of its 52-week high of $627.88, which the company achieved on September 10th.

Well, welcome to the 45th Annual TD Cowen Healthcare Conference. I'm Dan Brennan, follow Tools and Diagnostics. Really pleased to be joined on stage here with Marc Casper, Chairman and President of ...

Valued at a market cap of $200 billion, Thermo Fisher Scientific Inc. (TMO) is a Massachusetts-based powerhouse in scientific ...

DelveInsight's In Situ Hybridization Market Insights report provides the current and forecast market analysis, individual ...

Los Angeles County Science and Engineering Fair will welcome more than 1,400 students Sunday, March 9, and Monday, March 10, ...

Jabil Inc. (NYSE: JBL) has released its fiscal year 2024 Sustainability Progress Report, detailing the strides the company ...

The demand for in situ hybridization is experiencing significant growth, mainly due to the rising rates of cancer and genetic disorders. This trend is further driven by the increasing incidence ...

The microbial fermentation technology market is experiencing significant growth, fueled by the increasing incidence of chronic diseases like cancer a ...

Zika Virus Testing Market 2032 The global zika virus testing market is set to grow from USD 5.1 Mn in 2025 to USD 6.9 Mn by 2032, registeri ...

With a market cap of $148.5 billion, Washington, the District Of Columbia-based Danaher Corporation (DHR) is a global ...

Boston Scientific looks to catch up with Medtronic and Recor Medical in the much-hyped renal denervation space with its ...

The Marlborough medical device firm will pay $360 million upfront to buy SoniVie Ltd., a private medical device company in ...